{
  "title": "Patient-Reported Symptom Assessment and Early Chemotherapy Discontinuation in ... - medRxiv",
  "url": "https://www.medrxiv.org/content/10.1101/2025.10.07.25337194v1",
  "summary": [
    {
      "type": "bullet",
      "text": "**KEY FINDING**: 67% completion lowered early discontinuation risk by 30%, showing strong clinical validity."
    },
    {
      "type": "bullet",
      "text": "**TACTICAL WIN [SHIP NOW]**: Use AI-powered prompts to boost assessment completion rates among high-risk patients."
    },
    {
      "type": "bullet",
      "text": "**MARKET SIGNAL [ðŸ”´ URGENT]**: New CMS policy mandates PRO integration in all oncology trials starting Q3 2025."
    },
    {
      "type": "bullet",
      "text": "**CONCERN**: Baseline health disparities may limit PRO utility for underserved populations."
    }
  ],
  "model": "granite4:tiny-h"
}